Joincare Pharmaceutical Group Industry Co Ltd (600380) — Long-term Investment Intensity

Latest as of September 2019: 8.7%

Joincare Pharmaceutical Group Industry Co Ltd (600380) has a Long-term Investment Intensity of 8.7% as of September 2019. Long-term investments of CN¥2.07 Billion represent 8.7% of total assets of CN¥23.80 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See net assets of Joincare Pharmaceutical Group Industry C for net asset value and shareholders' equity analysis.

LT Investment Intensity

8.7%
LT Investments / Total Assets

Long-term Investments

CN¥2.07 Billion
CNY

Total Assets

CN¥23.80 Billion
CNY

Country

China
SHG

Joincare Pharmaceutical Group Industry Co Ltd Long-term Investment Intensity (2015–2018)

This chart shows how Joincare Pharmaceutical Group Industry Co Ltd's Long-term Investment Intensity has evolved across 3 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 8.7%, reflecting long-term investments of CN¥2.07 Billion against total assets of CN¥23.80 Billion CNY. Also explore 600380 asset base for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for Joincare Pharmaceutical Group Industry Co Ltd (2015–2018)

The table below presents the year-by-year Long-term Investment Intensity for Joincare Pharmaceutical Group Industry Co Ltd from 2015 to 2018, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of Joincare Pharmaceutical Group Industry C.

Year LT Investment Intensity LT Investments (CNY) Total Assets Change (pp)
2018 7.5% CN¥1.87 Billion CN¥24.99 Billion ▼ -2.2 pp
2016 9.7% CN¥1.55 Billion CN¥16.07 Billion ▲ +1.7 pp
2015 7.9% CN¥1.09 Billion CN¥13.80 Billion
pp = percentage points